coloaded the hydrophobic chemotherapeutic drug doxorubicin (DTX) and Incorporation of cholesterol‐modified TLR9 agonist in synthetic high‐density lipoprotein cholesterol (HDL) nanodiscs, and found that the use of DTX‐sHDL/CpG inhibited tumor growth and prolonged animal life.312, 313. The gene discussed is TLR9; the disease is neoplasm.